Regenexx Wins Second EHIR Award in as Many Years
Did you know that employers get together to find new ways to save money on healthcare? The main event in that world is called EHIR, which stands for the Employer Health Innovation Roundtable. Regenexx was awarded a lead innovator award last year and it just received its second such award this week. Let’s dig in.
What is EHIR?
Employer Health Innovation Roundtable is a coalition of the largest and most progressive employers who want to accelerate the adoption of innovation. Twice a year they run a “dating service” of sorts where Fortune 500 companies get matched with healthcare innovators trying to improve their employee healthcare while saving money. The companies hear pitches from healthcare innovators and then list their top choices.Request a Regenexx Appointment
Which Companies Make Up EHIR?
The company list is above. As you can see there are many Fortune 500 companies including American Airlines, Apple, AT&T, BestBuy, Boeing, Cargill, Chevron, CocaCola, Comcast, Delta, Disney, Google, HP, Hyatt, Johnson & Johnson, Liberty Mutual, Medtronic, Microsoft, Nasdaq, Pepsi, Progressive, Prudential, StateFarm, Target, Tesla, Home Depot, Travellers, United, Walmart, and Xcel Energy.
The EHIR Traction Award
The top innovators at EHIR that get matched with the most companies get a “Traction Award”. Regenexx got a traction award in 2019 and just got another one:
Regenexx had the highest number of matches in EHIR history last year and also has a high number of interested companies this year.
What is Regenexx Pitching to Employers?
Regenexx is signing up employers who want to reduce their orthopedic costs. Based on the data we have collected, we can save these companies large amounts of money and save their employees from invasive surgeries by moving them toward interventional orthobiologics. To learn more, see my video below:
The upshot? Regenexx continues to sign up large companies who want to both save money and reduce the number of surgeries needed by their employees. We also continue to rock the EHIR competition because companies want to thread the needle between saving money and providing better healthcare.